ATE489994T1 - Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen - Google Patents

Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen

Info

Publication number
ATE489994T1
ATE489994T1 AT06787437T AT06787437T ATE489994T1 AT E489994 T1 ATE489994 T1 AT E489994T1 AT 06787437 T AT06787437 T AT 06787437T AT 06787437 T AT06787437 T AT 06787437T AT E489994 T1 ATE489994 T1 AT E489994T1
Authority
AT
Austria
Prior art keywords
compositions
cees
treatment
inflammatory diseases
delivered
Prior art date
Application number
AT06787437T
Other languages
English (en)
Inventor
Gilbert Gonzales
Nicolas Chronos
Original Assignee
Clear Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Vascular Inc filed Critical Clear Vascular Inc
Application granted granted Critical
Publication of ATE489994T1 publication Critical patent/ATE489994T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)
AT06787437T 2005-07-20 2006-07-13 Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen ATE489994T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70137105P 2005-07-20 2005-07-20
PCT/US2006/027526 WO2007015774A2 (en) 2005-07-20 2006-07-13 Methods and compositions for treating luminal inflammatory disease

Publications (1)

Publication Number Publication Date
ATE489994T1 true ATE489994T1 (de) 2010-12-15

Family

ID=37709042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06787437T ATE489994T1 (de) 2005-07-20 2006-07-13 Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen

Country Status (6)

Country Link
US (3) US7874975B2 (de)
EP (1) EP1909901B8 (de)
AT (1) ATE489994T1 (de)
DE (1) DE602006018619D1 (de)
ES (1) ES2353532T3 (de)
WO (1) WO2007015774A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US8283167B2 (en) * 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
JP2016522832A (ja) * 2013-05-23 2016-08-04 ニューロエスエヌ・インコーポレイテッド 放射性核種で標識したアネキシンを使用したアルツハイマー病の診断及び治療

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647445A (en) 1984-03-28 1987-03-03 Massachusetts Institute Of Technology Radiolabelled lipoproteins and method for making same
US4937067A (en) 1984-12-13 1990-06-26 Massachusetts Institute Of Technology Method and means for detection of adrenal metabolic activity
US4660563A (en) 1984-12-31 1987-04-28 Massachusetts Institute Of Technology Method and means for detection of arterial lesions
US5225181A (en) 1985-06-07 1993-07-06 The Research Foundation Of State University Of New York Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi
US4877599A (en) 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
JPH03505094A (ja) 1988-05-02 1991-11-07 ニュー　イングランド　ディーコネス　ホスピタル　コーポレイション 動脈映像のための合成ペプチド
US5726153A (en) 1988-05-02 1998-03-10 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
CA1340977C (en) 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5334729A (en) 1989-06-29 1994-08-02 Associated Universities, Inc. Stable radiometal antibody immunoconjugates
US5216130A (en) * 1990-05-17 1993-06-01 Albany Medical College Complex for in-vivo target localization
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
WO1993017719A1 (en) 1992-03-13 1993-09-16 Diatech, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
US5292938A (en) 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5429133A (en) 1992-12-18 1995-07-04 Neoprobe Corporation Radiation responsive laparoscopic instrument
US5428156A (en) 1993-04-02 1995-06-27 Associated Universities, Inc. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
JP3122319B2 (ja) * 1994-05-02 2001-01-09 アソシエーティド ユニバーシティーズ，インコーポレイティド 錫−１１７ｍ−含有放射性治療剤
US5783169A (en) 1995-07-26 1998-07-21 Brookhaven Science Associates Llc Rigid bifunctional chelating agents
US5811814A (en) 1996-02-12 1998-09-22 Cordis Corporation Radiation measuring catheter apparatus and method
JP4963748B2 (ja) 1997-04-30 2012-06-27 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー 細胞死をｉｎ ｖｉｖｏで撮像する方法
US6500108B1 (en) 1999-10-22 2002-12-31 The Regents Of The University Of California Radiation delivery system and method
IL157444A0 (en) * 2001-02-23 2004-03-28 Bristol Myers Squibb Pharma Co Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same
EP1401479B1 (de) * 2001-06-04 2007-04-18 The General Hospital Corporation Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen
US6549802B2 (en) 2001-06-07 2003-04-15 Varian Medical Systems, Inc. Seed localization system and method in ultrasound by fluoroscopy and ultrasound fusion
US20030152513A1 (en) 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease

Also Published As

Publication number Publication date
DE602006018619D1 (de) 2011-01-13
EP1909901A4 (de) 2009-09-23
US20140212356A1 (en) 2014-07-31
US20110077211A1 (en) 2011-03-31
EP1909901B8 (de) 2011-02-02
US7874975B2 (en) 2011-01-25
US9283290B2 (en) 2016-03-15
WO2007015774A3 (en) 2007-11-01
WO2007015774A2 (en) 2007-02-08
EP1909901A2 (de) 2008-04-16
US20070021641A1 (en) 2007-01-25
EP1909901B1 (de) 2010-12-01
ES2353532T3 (es) 2011-03-02
US8753255B2 (en) 2014-06-17

Similar Documents

Publication Publication Date Title
CY1125077T1 (el) Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
CY1115289T1 (el) Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
EA200802213A1 (ru) Способы лечения заболеваний крови
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
CY1111437T1 (el) Τετραϋδροπυρρολοπυριμιδινοδιονες και η χρηση τους ως αναστολεων της ανθρωπινης ουδετεροφιλης ελαστασης
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE392219T1 (de) Methoden und medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs
DE602004018119D1 (de) Vorrichtung zur wirkstofffreisetzung mit einer netzhülse
EA201070193A1 (ru) Лечение детских опухолей
ATE489994T1 (de) Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen
ATE536368T1 (de) Konjugate von zytotoxischen verbindungen mit peptiden
TW200640467A (en) Compounds and uses thereof
WO2007146375A3 (en) Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
ATE540920T1 (de) Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie
DE502007003367D1 (de) Pharmazeutische zusammensetzung zur behandlung von inkontinenz
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
DK1962822T3 (da) Terapi af maligne neoplasier
MD3446G2 (ro) Metodă de tratament al infecţiei HIV

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties